Shanghai, July 16, 2012--Approved by MicroPort's Board of Directors, Mr. Jonathan Chen formally assumed the position as Vice President in International Business & Investor Relations yesterday. Mr. Jonathan has 14 years of experience in life science industry including as Senior Vice President, Business Development & Financial Strategy at Angiotech Pharmaceuticals, Inc. based in Canada from 2005 to 2011and Senior Vice President, Health Industry Investment at Credit Suisse First Boston. Mr. Jonathan received his undergrad dual degree in Bioscience and Economics from Stanford University in 1997.
In addition, Mr. Phillip Wang (Wang Li), former COO responsible for the International Business, resigned voluntarily and Board of Directors approved his proposal.
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.